Clinical Trials Insight: 700046332
Latest Information Update: 25 Jun 2009
Price :
$35 *
At a glance
- Drugs Melogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Glenmark Pharmaceuticals Ltd
- 25 Jun 2009 New trial record.